QNRX · Quoin Pharmaceuticals Ltd. · Documents
$4.05
+0.04 (+1.00%)
At close · Oct 27
Return incl. dividend (before tax)
Q4 2023 earnings call transcript
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based upon the Company's current business plans and cash, cash equivalents, and investments on hand, management has concluded that there is substantial doubt about the Company's ability to continue as a going concern for a period of at least one year from the date of the filing of this Quarterly Report on Form 10-Q.”View the 10-Q filed Aug 14, 2026
Market Cap
$19.26M
Shares
4.80M
Volume · Oct 27
1522
Avg daily vol (3M)
536.56K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 6-K/A | — | 2021-02-11 | 2020-06-30 | |
| 6-K | — | 2020-11-20 | — | |
| 6-K | — | 2020-11-09 | — | |
| 6-K | — | 2020-11-02 | 2020-11-01 | |
| 6-K | — | 2020-10-29 | — | |
| 6-K | — | 2020-10-22 | — | |
| 6-K | — | 2020-10-20 | — | |
| 6-K | — | 2020-10-13 | — | |
| 6-K | — | 2020-09-25 | — | |
| 6-K | — | 2020-09-21 | — | |
| 6-K | — | 2020-08-12 | — | |
| 6-K | — | 2020-08-06 | — | |
| 20-F/A | — | 2020-08-04 | 2019-12-31 | |
| 6-K | — | 2020-06-03 | — | |
| 6-K | — | 2020-05-27 | — | |
| 6-K | — | 2020-05-21 | — | |
| 6-K | — | 2020-05-18 | — | |
| 6-K | — | 2020-05-12 | — | |
| 6-K | — | 2020-05-11 | — | |
| 6-K | — | 2020-04-27 | — | |
| 6-K | — | 2020-04-22 | — | |
| 6-K | — | 2020-04-03 | — | |
| 20-F | — | 2020-04-03 | 2019-12-31 | |
| 6-K | — | 2020-04-02 | — | |
| 6-K | — | 2020-03-04 | 2020-03-03 | |
| 6-K | — | 2020-01-27 | — | |
| 6-K | — | 2020-01-10 | — | |
| 6-K | — | 2020-01-10 | 2020-01-09 | |
| 6-K | — | 2020-01-08 | — | |
| 6-K | — | 2020-01-07 | — | |
| 6-K | — | 2020-01-06 | — |
Showing 151–181 of 181 filings